Biosimilars: recent developments.

Biosimilars: recent developments. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Biosimilars: recent developments. Abstract Text:

A Covic,M K Kuhlmann,

Biopharmaceuticals are recombinant protein drugs which are produced by biotechnology. The availability of such molecules has revolutionised the way we treat many diseases. However, the patents for many originator biopharmaceuticals are expiring, and a new generation of follow-on molecules, termed "biosimilars", are under development. Health care providers perceive biosimilars to be cheap replacements for originator drugs such as recombinant human erythropoietin and human growth hormone. However, concerns have been raised about the comparability of biosimilars with originator products especially in light of the complex manufacturing process required to produce biopharmaceuticals. The complexity of protein molecules renders it impossible to produce identical copies; this in turn raises questions on the safety of follow-on biosimilar products, particularly with respect to immunogenicity. This review briefly outlines the process of biopharmaceutical production, potential problems that can arise from their long-term use in patients, and the issues facing regulatory bodies as they look to institute guidelines for new biosimilar molecules.

Biosimilars: recent developments. Publishing Authors By Initials

A Covic,MK Kuhlmann,

For similar proteins: recombinant proteins research abstracts see: proteins: recombinant proteins research

PUBMED ID PMID:

MEDLINE DATE:

Biosimilars: recent developments. Journal Published:

PUBLICATION TYPE: Review

Journal: International urology and nephrology

VOLUME: 39

Page Numbers: 261-6

Journal Abbreviation:

ISSN: 0301-1623

DAY: 27

MONTH: 02

YEAR: 2007

Biosimilars: recent developments. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 262521

Biosimilars: recent developments. Keywords Mesh Terms:

KEYWORDS: Recombinant Proteins

MESH TERMS: immunology

Chemical & Substance for Abstract: Biosimilars: recent developments. Information

Substance Name: Recombinant Proteins

Registry Number: 0

Grant and Affiliation Information for Biosimilars: recent developments.

AFFILIATION: Dialysis and Transplantation Centre, C.I. Parhon University Hospital, Iasi 700503, Romania. acovic@xnet.ro

Country: Hungary

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Int Urol Nephrol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Biosimilars: recent developments Related Publications

• Alpha-fetoprotein: cellular origin of a biological marker in rat liver under various experimental conditions.
• Annual rainfall does not directly determine the carbon isotope ratio of leaves of Eucalyptus species.
• BAROS: an effective system to evaluate the results of patients after bariatric surgery.
• Biosimilars: recent developments.
• Does a history of peritoneal dialysis result in an impaired gastrointestinal life quality?
• Does gastric restriction surgery reduce the risks of metabolic diseases?
• Effect of rioprostil, a methyl-prostaglandin E1, on plasma level and renal excretion of beta-acetyldigoxin.
• Ethylene tetramerization: a new route to produce 1-octene in exceptionally high selectivities.
• Intradermal hepatitis B vaccination in nonresponsive hemodialysis patients.
• Invited commentary from members on the draft proposal released by the Centers for Medicare & Medicaid Services for modification of national coverage determination 240.4.
• Miniaturization of Primary Porcine Urinary Bladder Epithelial Cell Cultures and Application for Gene Expression Studies after Exposure to Benzo[a]Pyrene.
• Properties and operation of a 90 degrees spherical deflector as photoelectron energy analyzer in connection with spin-polarization measurements by Mott scattering.
• The European Service Mapping Schedule (ESMS): development of an instrument for the description and classification of mental health services.
• Treatment of venous leg ulcers with topical iloprost: a placebo controlled study.
• [Adhesive (obstructive) pericarditis]
• [Case of an aneurysm of the common hepatic artery]
• [Epidermophyton Kaufmann-Wolf and Candida albicans infections in guinea pigs sensitized with chloro-dinitrobenzene and benzene; preliminary report.]
• [Evaluation of internally administered fungicides in animal experiments.]
• [Intrapleural remaining empyema cavity. A contribution to the direct study of the patient]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Overweight. Contribution on the formation of various types, its prevention and elimination]
• [Studies on the cellular localization of alpha 1 fetoprotein under normal and pathological conditions]
• [Surgery for obesity: a current trend or a specialty to be taken seriously?]
• [The first ray of the hand and the foot of the primates (I). Descriptive anatomy.]
• [Treatment of nicotine-induced circulatory diseases of the legs]
• [Treatment recommendations for lumbago]